Search research articles
Contact Us
Filters
Showing results (111-120 of 1,071) with videos related to
Page
of 108
Sort By:
Stroke
|
January 6, 2007
Update on the genetics of stroke and cerebrovascular disease 2006
Martin Dichgans, Robert A Hegele
Experimental Cell Research
|
May 1, 2007
Phenomics and lamins: from disease to therapy
Robert A Hegele, Junko Oshima
Expert Opinion on Investigational Drugs
|
July 30, 2013
Current Phase II proprotein convertase subtilisin/kexin 9 inhibitor therapies for dyslipidemia
Paul Lee, Robert A Hegele
The Canadian Journal of Cardiology
|
November 26, 2016
The Sum of Its Parts: The Polygenic Basis of Coronary Artery Disease
Ruth McPherson, Robert A Hegele
Journal of Human Genetics
|
July 14, 2001
Single nucleotide polymorphisms of RXRA encoding retinoid X receptor alpha
R A Hegele, H Cao
Journal of Human Genetics
|
March 18, 2000
Human cathepsin S gene (CTSS) promoter -25G/A polymorphism
H Cao, R A Hegele
Human Genetics
|
February 8, 2003
Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH)
Jian Wang, Robert A Hegele
The Lancet. Diabetes & Endocrinology
|
December 13, 2016
PCSK9 inhibition and diabetes: turning to Mendel for clues
Jooho Lee, Robert A Hegele
Current Opinion in Endocrinology, Diabetes, and Obesity
|
November 28, 2021
Advances in the care of lipodystrophies
Isabel Shamsudeen, Robert A Hegele
The Lancet. Diabetes & Endocrinology
|
April 16, 2014
Inducing thyrotoxicosis in the liver to treat raised cholesterol
Robina Rana, Robert A Hegele
Page
of 108
Search research articles
Search
Showing results (111-120 of 1,071) with videos related to
Sort By:
Page
of 108
Stroke
|
January 6, 2007
Update on the genetics of stroke and cerebrovascular disease 2006
Martin Dichgans, Robert A Hegele
Experimental Cell Research
|
May 1, 2007
Phenomics and lamins: from disease to therapy
Robert A Hegele, Junko Oshima
Expert Opinion on Investigational Drugs
|
July 30, 2013
Current Phase II proprotein convertase subtilisin/kexin 9 inhibitor therapies for dyslipidemia
Paul Lee, Robert A Hegele
The Canadian Journal of Cardiology
|
November 26, 2016
The Sum of Its Parts: The Polygenic Basis of Coronary Artery Disease
Ruth McPherson, Robert A Hegele
Journal of Human Genetics
|
July 14, 2001
Single nucleotide polymorphisms of RXRA encoding retinoid X receptor alpha
R A Hegele, H Cao
Journal of Human Genetics
|
March 18, 2000
Human cathepsin S gene (CTSS) promoter -25G/A polymorphism
H Cao, R A Hegele
Human Genetics
|
February 8, 2003
Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH)
Jian Wang, Robert A Hegele
The Lancet. Diabetes & Endocrinology
|
December 13, 2016
PCSK9 inhibition and diabetes: turning to Mendel for clues
Jooho Lee, Robert A Hegele
Current Opinion in Endocrinology, Diabetes, and Obesity
|
November 28, 2021
Advances in the care of lipodystrophies
Isabel Shamsudeen, Robert A Hegele
The Lancet. Diabetes & Endocrinology
|
April 16, 2014
Inducing thyrotoxicosis in the liver to treat raised cholesterol
Robina Rana, Robert A Hegele
Page
of 108